David Fallace is a Managing Partner and Co-Founder of Cure Ventures. He has over 20 years of experience investing in venture capital and alternative asset funds.
At firms with a similar stage, sector and check size.
One email when David's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckDavid Fallace is a Managing Partner and Co-Founder of Cure Ventures. He has over 20 years of experience investing in venture capital and alternative asset funds.
Cure Ventures has not reported a check size. It invests at pre-seed, seed, series a, series b.
Email [email protected], the firm's inbox for founders, and name David in the subject. A warm intro from a founder Cure Ventures backed works better.
GF Private Equity Group; Director of Investments at Alaska Permanent Fund Corporation; Managing Director at TIFF Investment Management; advisor at Polaris Partners; Expert-in-Resident at Harvard University’s Office of Technology Development.
Last updated 2026-10-15. Is this you? Ask for a correction.